Active substance
Hydroxyethyl starch
- SFDA 13
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| HAES-STERIL 10% INFUSION | 10 % | Solution for infusion · Parenteral use | 1 Bag | SAR 90.85 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by MAH · Not Marketed |
| HAES-STERIL 10% INFUSION | 10 % | Solution for infusion · Parenteral use | 1 Bottle | SAR 92.05 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by MAH · Not Marketed |
| HAES-STERIL 6% IN N.SALINE Infusion* | 6 % | Infusion · Parenteral use | 1 Bottle | SAR 71.10 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by MAH · Not Marketed |
| HESPAND 6% W-V STERILE SOLN Infusion* | 6 % | Solution · Parenteral use | 1 Bottle | SAR 82.20 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by regulatory authority · Not Marketed |
| HESPAND 6% W-V STERILE SOLN Infusion* | 6 % | Solution · Parenteral use | 1 Bag | SAR 69.00 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by regulatory authority · Not Marketed |
| PLASMA STERIL Infusion* | 6 % | Infusion · Parenteral use | 1 Bottle | SAR 71.75 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by MAH · Not Marketed |
| PLASMA STERIL Infusion* | 6 % | Infusion · Parenteral use | 1 Bottle | SAR 73.05 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by MAH · Not Marketed |
| PLASMEX 6% W-V STERILE SOLN INFUSION | 6 % | Solution for infusion · Intravenous use | 1 Bottle | SAR 66.40 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by regulatory authority · Not Marketed |
| PLASMEX 6% W-V STERILE SOLN INFUSION | 6 % | Solution for infusion · Intravenous use | 1 Bag | SAR 55.35 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by regulatory authority · Not Marketed |
| VOLUVEN I.V INFUSION | 6 % | Solution for infusion · Parenteral use | 1 Bag | SAR 45.70 | Generic · Prescription | FRESENIUS KABI | Withdrawn by regulatory authority · Not Marketed |
| VOLUVEN I.V INFUSION | 6 % | Solution for infusion · Parenteral use | 1 Bottle | SAR 65.15 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by MAH · Not Marketed |
| VOLUVEN I.V INFUSION | 6 % | Solution for infusion · Parenteral use | 1 Bottle | SAR 72.80 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by MAH · Not Marketed |
| VOLUVEN I.V INFUSION | 6 % | Solution for infusion · Parenteral use | 1 Bag | SAR 62.25 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by MAH · Not Marketed |
Safety signals and safety-related labeling changes
- EMA PRAC 31 Oct 2012 PRAC signal: Increased risk of mortality versus Ringer's acetate in severe sepsis
Action for MAH: update of the product information: No
Combinations containing Hydroxyethyl starch
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.